Billing Code Overview

CPT code 0164U is a Proprietary Laboratory Analyses (PLA) code for the ibs–smart™ blood test developed by Gemelli Biotech. The test measures antibodies anti–CdtB and anti–vinculin, two validated biomarkers associated with irritable bowel syndrome (IBS), and applies an algorithm to identify IBS with a diarrheal component or indicate the need for further diagnostic evaluation.

Service Type: Proprietary laboratory diagnostic test (serology with algorithmic interpretation)

Typical Site of Service: Clinical laboratory or outpatient phlebotomy site with laboratory analysis

Clinical Context

A 34-year-old adult presents to a gastroenterology clinic with a 6‑month history of recurrent abdominal pain, increased stool frequency, and loose stools consistent with a diarrheal pattern. The clinician documents symptoms consistent with irritable bowel syndrome with diarrhea (IBS‑D) after initial history and physical exam and excludes alarm features (weight loss, GI bleeding, family history of IBD/colon cancer). The clinician orders the proprietary blood test 0164U (ibs–smart™ by Gemelli Biotech) to measure anti‑CdtB and anti‑vinculin antibodies and apply the test algorithm to support a diagnosis of IBS with diarrheal component or to indicate need for additional diagnostic evaluation.

Typical clinical workflow:

• Patient presents to outpatient gastroenterology or primary care clinic for evaluation of chronic diarrhea and abdominal pain.

• Clinician documents symptom history, medication review, and relevant negative alarm signs; obtains basic labs (CBC, CMP) and stool testing as clinically indicated.

• If clinical suspicion for post‑infectious IBS or IBS‑D remains, clinician orders 0164U through the clinic’s laboratory ordering system or the proprietary lab vendor.

• Venous blood sample is collected in the outpatient phlebotomy area or clinic and sent to the performing laboratory according to the vendor’s handling requirements.

• Laboratory performs the proprietary assay measuring anti‑CdtB and anti‑vinculin antibodies and runs the algorithm; a report is returned to the ordering clinician indicating a positive, negative, or indeterminate result and any recommended next steps per the test report.

• Clinician integrates the test result with clinical findings to confirm an IBS‑D diagnosis, counsel the patient, and plan management or order further testing if indicated (for example, celiac serologies, colonoscopy if alarm features develop).

Coding Specifications

22 | Increased procedural services | Use when work required to process or document the test is substantially greater than typical, if payer allows for PLA laboratory reporting with modifier for unusual effort

26 | Professional component | Use when only the professional interpretation/reporting portion of the laboratory test is billed separately and applicable under payer policy

52 | Reduced services | Use when the laboratory performed a reduced portion of the service compared with full test

54 | Surgical care only | Not typically applicable to this laboratory test; included when billing conventions require separation of care phases

55 | Post‑operative management only | Not typically applicable to this laboratory test

62 | Two surgeons | Not applicable to this laboratory test; applicable in surgical encounters

78 | Return to OR for related procedure | Not applicable to this laboratory test

80 | Assistant surgeon | Not applicable to this laboratory test

82 | Assistant surgeon (when qualified resident unavailable) | Not applicable to this laboratory test

AD | Advanced diagnostic imaging modifier (payer‑specific) | Use per payer when reporting advanced diagnostic components if applicable to the reporting or billing policy for proprietary tests

AS | Physician assistant, nurse practitioner, or clinical nurse specialist services | Use when services related to test ordering or specimen collection are furnished by these clinicians and payer accepts modifier

CO | Contractual obligation | Use to indicate charge adjustment due to contractually required discount or write‑off

QK | Medical direction of 2–4 ancillary staff | Use if the ordering or supervising physician qualifies under payer rules for medical direction in specimen collection workflows

TC | Technical component | Use when billing only the technical component of the laboratory test (instrumentation, reagents, technician time) and payable separately

208D00000X | Family Medicine | Primary care physicians may order the test as part of initial evaluation of chronic diarrhea prior to GI referral

207L00000X | Internal Medicine | General internists evaluating chronic GI symptoms order and interpret results to guide management

363LP0800X | Clinical Laboratory | Clinical laboratory specialists perform, validate, and report proprietary PLA tests; responsible for technical and reporting components

261QM0800X | Phlebotomy | Phlebotomists perform specimen collection and handling per vendor instructions

Related Diagnoses

K58.9 | Irritable bowel syndrome without diarrhea (IBS, unspecified) | Relevant when clinician considers IBS subtyping; test may help identify diarrheal component

R19.7 | Diarrhea, unspecified | Symptom code commonly present when evaluating for IBS‑D and when ordering antibody testing

A09 | Infectious gastroenteritis and colitis, unspecified | Used when evaluating post‑infectious etiology or history of antecedent gastroenteritis contributing to symptoms

R10.9 | Abdominal pain, unspecified | Frequently documented symptom prompting evaluation including 0164U testing

K90.0 | Celiac disease | Differential diagnosis to exclude when evaluating chronic diarrhea; often part of parallel testing strategy

K52.9 | Noninfective gastroenteritis and colitis, unspecified | Differential consideration in chronic diarrheal presentations

Related CPT Codes

83036 | Hemoglobin; glycosylated (A1C) | Example blood chemistry test that may be ordered concurrently to evaluate metabolic causes of symptoms in the initial workup

80053 | Comprehensive metabolic panel | Commonly performed in parallel to assess electrolytes, renal and hepatic function when evaluating chronic diarrhea

80061 | Lipid panel | May be ordered as part of general medical evaluation but not specific to this PLA test

82270 | Blood, occult, gastrointestinal; qualitative | Stool occult blood testing may be ordered in differential diagnosis of chronic diarrhea and to exclude gastrointestinal bleeding

88305 | Surgical pathology, gross and microscopic examination | Colon biopsy pathology performed if colonoscopy is indicated after initial noninvasive testing; follows when invasive evaluation is required